A Randomised Trial of the Impact of New Faecal Haemoglobin Test Technologies on Population Participation in Screening for Colorectal Cancer

Mandel JS Bond JH Church TR Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365–71.

Hardcostle JD Chamberlain JO Robinson MHE Randomised controlled trial of fecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472–7.

Kronborg O Fenger C Olsen J Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467–71.

Mandel JS Church TR Bond JH The effect of fecal occult blood screening on the incidence of colorectal cancer. New Engl J Med 2000;343:1603–7.

Greegor DH. Diagnosis of large-bowel cancer in the asymptomatic patient. JAMA 1967;201:943–5.

Greegor DH. Occult blood testing for detection of asymptomatic colon cancer. Cancer 1971;28:131–4.

Young GP Macrae FA St John DJB. Clinical methods of early detection: Basis, use and evaluation. In: Young GP Levin B Rozen P , eds. Prevention and early detection of colorectal cancer. London: WB Saunders, 1996: 241–70.

Jaffe RM Kasten B Young DS False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med 1975;83:824–6.

Macrae FA St John DJB Caligiore P Optimal dietary conditions for Hemoccult testing. Gastroenterology 1982;82:899–903.

Simon JB. Occult blood screening for colorectal carcinoma: A critical review. Gastroenterology 1985;88:820–37.

Young GP St John DJB. Faecal occult blood tests: Choice, usage and clinical applications. Clin Biochem Rev 1992;13:161–7.

Young GP St John DJB Winawer SJ Choice of fecal occult blood tests for colorectal cancer screening: Recommendations based on performance characteristics in population studies. Am J Gastroenterol, 2002;97:2499–507.

Adams EC Layman KM. Immunochemical confirmation of gastrointestinal bleeding. Ann Clin Lab Sci 1974;4:343–9.

Barrows GH Burton RM Jarrett DD Immunochemical detection of human blood in faeces. Am J Clin Path 1978;69:342–6.

Saito H Tsuchida S Fukushi M An immunological occult blood test for mass screening of colorectal cancer by reverse passive hemagglutination (RPHA). Jap J Gastroenterol 1984; 81:2831–3.

St John DJB Young GP. Is there a need to restrict diet in occult blood screening for colorectal cancer? Gastroenterology 1992;102:A402.

Adlercreutz H Partanen P Virkola P Five guaiac-based tests for occult blood in faeces compared in vitro and in vivo. Scand J Clin Lab Invest 1984; 44:519–28.

Young GP St John DJB. Selecting an occult blood test for use as a screening tool for large bowel cancer. Front Gastrointest Res 1991; 18:135–56.

McDonald CA Burford Y Yuen AC Immunochemical detection of faecal occult blood. Aust N Z J Med 1984; 14:105–10.

Allison JE Tekawa IS Ransom U A comparison of fecal occult blood tests for colorectal cancer screening. N Engl J Med 1996:334:154–9.

Hardcastle JD Thomas WM Chamberlain J Randomised, controlled trial of faecal occult blood screening for colorectal cancer: Results for the first 107,349 subjects. Lancet 1989;1 (8648): 1160–4.

St John DJB Young GP Alexeyeff MA Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 1993;104:1661–8.

King J Fairbrother G Thompson C Colorectal cancer screening: Optimal compliance with postal faecal blood test. Aust N Z J Surg 1992;62:714–9.

Joseph A . Compliance with fecal occult blood testing: The role of restrictive diets. Am J Public Health 1988;78:839–41.

Robinson MHE Pye G Thomas WM Haemoccult screening for colorectal cancer: The effect of dietary restriction on compliance. Europ J Surg Oncol 1994;20:545–8.

Cole SR Young GP. Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer. Med J Aust 2001;175:195–8.

Vernon S . Participation in colorectal cancer screening: A review. J Notl Cancer Inst 1997;89:1406–22.

Ahlquist DA Schwartz S Isaacson J A stool collection device: The first step in occult blood testing. Ann Int Med 1988;108:609–12.

Nakama H Fattah A Zhang B A comparative study of immunochemical fecal tests for detection of colorectal adenomatous polyps. Hepato-Gastroenterol 2000:47:386–9.

Nakama H Kamijo N Miyata K Sensitivity and specificity of several immunochemical tests for colorectal cancer. Hepato-Gastroenterol 1998;45:1579–82.

Myers RE Vernon SW Tilley BC Intention to screen for colorectal cancer among white male employees. Prev Med 1998;27:279–87.

Frew E Wolstenholme J Whynes D . Mass population screening for colorectal cancer: Factors influencing subjects' choice of screening test. J Health Serv Res Policy 2001;6:85–91.

Friedman LC Everett TE Peterson L Compliance with fecal occult blood test screening among low-income medical outpatients: A randomized controlled trial using a videotaped intervention. J Cancer Educ 2001;16:85–8.

Weinrich SP Weinrich MC Atwood J Predictors of fecal occult blood screening among older socioeconomically disadvantaged Americans: A replication study. Patient Educ Couns 1998;34:103–14.

Li T Nakama H Wei N . Reasons for non-compliance in colorectal cancer screening with fecal occult blood test. Eur J Med Res 1998;3:397–400.

Tazi MA Faivre J Dassonville F Participation in faecal occult blood screening for colorectal cancer in a well defined French population: Results of five screening rounds from 1988 to 1996. J Med Screen 1997;4:147–51.

Grazzini G Castiglione G Isu A Colorectal cancer screening by fecal occult blood testing: Results of a population-based experience. Tumori 2000;86:384–8.

Mandelson MT Curry SJ Anderson LA Colorectal cancer screening participation by older women. Am J Prev Med 2000;19:149–54.

Weller DP Owen N Hiller JE Colorectal cancer and its prevention: Prevalence of beliefs, attitudes, intentions and behaviour. Aust J Pub Health 1995;19:19–23.

Tong S Hughes K Oldenburg B Socio-demographic correlates of screening intention for colorectal cancer. Aust N Z J Pub Health 2000;24:610–4.

Frazier AL Colditz GA Fuchs CS Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000;284:1954–61.

Australian Bureau of Statistics. Census of population and housing: Socioeconomic indexes for areas (SEIFA), South Australia 2033.4.30.001. Available at http://www.abs.gov.au/austats/ (last accessed October 2002).

Cockburn J Paul C Tzelepis F Screening for bowel cancer among NSW adults with varying levels of risk: A community survey. Aust N Z J Pub Health 2002;26:236–41.

Rozen P Knaani J Samuel Z . Comparative screening with a sensitive guaiac and specific immunochemical occult blood test within an endoscopy study. Cancer 2000;89:46–52.

Sinatra MA St John DJB Young GP. Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable. Clin Chem 1999;45:123–6.

Rozen P Knaani J Samuel Z . Eliminating the need for dietary restrictions when using a sensitive guaiac fecal occult blood test. Dig Dis Sci 1999;44:756–60.

Gardner MJ Altman DG. Confidence intervals rather than P values: Estimation rather than hypothesis testing. BMJ 1986;292:746–50.

Young GP Rozen P Levin B . How should we screen for early colorectal neoplasia. In: Rozen P Young GP Levin B eds. Colorectal cancer in clinical practice: Prevention & early detection. London: Isis Publications, 2002: 77–99.

Lynch NM McHutchison JG Young GP Gastrointestinal blood loss from a new buffered aspirin (Ostoprin): Measurement by radiochromium and HemoQuant™ techniques. Aust N Z J Med 1989;19:89–96.

Pignone M Campbell MK Carr C Meta-analysis of dietary restriction during fecal occult blood testing. Eff Clin Pract 2001;4:150–6.

Cole SR Young GP Byrne D Participation in faecal occult blood test-based screening for colorectal cancer is improved by endorsement by the primary care practitioner. J Med Screen 2002;9:147–52.

Sutton S Wardle J Taylor T Predictors of attendance in the UK flexible sigmoidoscopy screening trial. J Med Screen 2000;7:99–104.

Herold AH Riker AL Warner EA Evidence of gender bias in patients undergoing flexible sigmoidoscopy. Cancer Detect Prevent 1997;21:141–7.